News

Damaged collagen detected by collagen hybridizing peptide as efficient diagnosis marker for early hepatic fibrosis

Liver fibrosis, a significant pathological consequence of chronic liver disease and damage, is characterized by the excessive accumulation of extracellular matrix (ECM) proteins. This build up of non-functional scar tissue progressively replaces healthy tissue in the liver, leading to conditions such as cirrhosis, liver failure, and heightened risk of liver cancer. With a high...
View Details

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation

Fibrosis is not just characterized by extracellular matrix (ECM) component deposition, but it’s better described as an imbalance between the production and breakdown of the ECM. Current treatments for fibrosis largely focus on stopping ECM production, but there is a significant, untapped potential in promoting its breakdown. Matrix metalloproteinases (MMPs) are enzymes that degrade...
View Details

A Novel Collagen Hybridizing Peptide for Activating LAIR-1 Inhibitory Pathway at Damaged Collagen Sites

ABSTRACT TITLE: A Novel Collagen Hybridizing Peptide for Activating LAIR-1 Inhibitory Pathway at Damaged Collagen Site AUTHORS: Regan Stephenson, Bridget Glass, Kyle Dunlap, Mallory Longacre, Lucas Bennink, Mike Kirkness AFFILIATIONS: 3Helix, Inc, Salt Lake City, Utah, USA     ABSTRACT: Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1), an inhibitory collagen receptor expressed on a variety of immune...
View Details